Send Inquiry

Request To Call Back

ERLONAT ERLOTINIB 100 MG TABLETS

Get a Price/Quote

ERLONAT ERLOTINIB 100 MG TABLETS Specification

Origin of Medicine
India

Dosage Form
Tablet

Pacakaging (Quantity Per Box)
30 Tablets

Salt Composition
Erlotinib 100 mg

Indication
Treatment of advanced or metastatic non-small cell lung cancer (NSCLC) and locally advanced, unresectable or metastatic pancreatic cancer

Drug Type
Allopathic

Ingredients
Erlotinib Hydrochloride

Physical Form
Tablets

Function
Anti-cancer (EGFR inhibitor)

Recommended For
Non-Small Cell Lung Cancer, Pancreatic Cancer

Dosage
As directed by oncologist, typically 100 mg once daily

Dosage Guidelines
Take on empty stomach, at least 1 hour before or 2 hours after food

Suitable For
Adults only

Quantity
30 Tablets per box

Storage Instructions
Store below 30C, protect from moisture and light

Administration Route
Oral

Therapeutic Classification
Tyrosine Kinase Inhibitor

Interaction
May interact with CYP3A4 inhibitors/inducers, anticoagulants

Strength
100 mg

Shelf Life
24 months from date of manufacture

Shape
Round, film-coated

Regulatory Approval
Approved for use in India

Brand Name
Erlonat

Warning
Not to be used in pregnant or breastfeeding women unless prescribed

Marketed By
Natco Pharma Ltd.

Color
White to off-white

Side Effects
Rash, diarrhea, fatigue, nausea, anorexia

Prescription Required
Yes

ERLONAT ERLOTINIB 100 MG TABLETS Trade Information

Packaging Details
PACK OF 30 TALETS

About ERLONAT ERLOTINIB 100 MG TABLETS

Erlonat Erlotinib

ERLONAT 100 MG TABLETS ERLOTINIB 100 MG

Erlonat is a medication, containing erlotinib, belonging to a class of medications termed as kinase inhibitors. Erlonat is used for treating non-small cell lung cancer. Erlonat, in combination with gemcitabine, is used for treating pancreatic cancer, which has been spread to near tissues or the other parts of the body. The medication is known for its efficacy in treatment of the cancer..

Specifications

Product Name - Erlonat 150 Mg Tablets
Content - Erlotinib Hydrochloride
Form - Tablets
Strength - 25 Mg, 100Mg, 150 Mg
Packing - Pack Of 30 Tablets
Manufactured By : Natco

Note:Erlonat Is A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice. Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug.............

Targeted Anti-Cancer Solution

Erlonat Erlotinib 100 mg targets the epidermal growth factor receptor (EGFR) pathway, which is crucial in the progression of non-small cell lung cancer and pancreatic cancer. By inhibiting this pathway, Erlonat slows tumor growth, offering a tailored approach for patients who require advanced cancer therapy.

Simple Oral Administration

These tablets are designed for convenient oral consumption, ideally once a day on an empty stomach. This not only simplifies the treatment regimen but also ensures optimal absorption and effectiveness, providing flexibility for patients undergoing long-term therapy.

Trusted Indian Manufacturing

Manufactured by Natco Pharma Ltd. and approved for use in India, Erlonat demonstrates high standards of quality and regulatory compliance. Patients and healthcare providers can rely on its efficacy and safety, which are supported by local and international guidelines.

FAQs of ERLONAT ERLOTINIB 100 MG TABLETS:

Q: How should I take Erlonat Erlotinib 100 mg Tablets?

A: You should swallow the tablet whole with water, ideally at least one hour before or two hours after a meal, as directed by your oncologist. Always follow your prescribed dosage instructions carefully.

Q: What are the primary uses of Erlonat Erlotinib 100 mg?

A: Erlonat is recommended for adults diagnosed with advanced or metastatic non-small cell lung cancer (NSCLC) and locally advanced, unresectable, or metastatic pancreatic cancer. It is prescribed as part of a targeted anti-cancer therapy.

Q: When should I avoid using Erlonat Tablets?

A: Erlonat should not be used by pregnant or breastfeeding women unless specifically directed by your doctor. Inform your healthcare provider about any existing medical conditions or other medications to avoid harmful interactions.

Q: Where should I store Erlonat Tablets to maintain their effectiveness?

A: Store the tablets below 30C, protected from moisture and light, and keep them in their original packaging until use. Improper storage may affect the quality and efficacy of the medicine.

Q: What potential side effects might I experience with Erlonat?

A: Common side effects may include rash, diarrhea, fatigue, nausea, and decreased appetite. Report any persistent or severe symptoms to your physician promptly.

Q: What drug interactions should I be aware of while taking Erlonat?

A: Erlonat may interact with medications such as CYP3A4 inhibitors/inducers and anticoagulants. Always inform your oncologist about all medications or supplements you are taking to prevent adverse effects.

Tell us about your requirement